Pure Global

IVD Department quantitative AFP testing - Vietnam Registration 2403601ĐKLH/BYT-HTTB

Access comprehensive regulatory information for IVD Department quantitative AFP testing in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại C medical device is registered under number 2403601ĐKLH/BYT-HTTB. The authorized representative in Vietnam is VĂN PHÒNG ĐẠI DIỆN LIFE TECHNOLOGIES HOLDINGS PTE. LTD. TẠI THÀNH PHỐ HỒ CHÍ MINH.

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Theo phụ lục, and 1 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
1 Competitors
1 Recent Registrations
2403601ĐKLH/BYT-HTTB
Registration Details
Vietnam MOH Registration: 2403601ĐKLH/BYT-HTTB
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

IVD Department quantitative AFP testing
VN: Bộ IVD xét nghiệm định lượng AFP
Risk Class TTBYT Loại C

Registration Details

2403601ĐKLH/BYT-HTTB

000.00.04.G18-240801-0003

Theo theo phụ lục

Theo phụ lục

Technical Details

*) B·R·A·H·M·S AFP KRYPTOR (Product Code: 816075N): The B·R·A·H·M·S AFP KRYPTOR test is an automated fluorescent immunoassay for the quantitative determination of alpha-fetoprotein (AFP) concentration in serum, plasma (heparin), and amniotic fluid. The B·R·A·H·M·S AFP KRYPTOR test is indicated for use in conjunction with other test results and clinical data as a non-invasive screening tool for the risk of trisomy 21 in the fetus in the first trimester and trisomy 21 and 18 in the fetus in the second trimester of pregnancy. The B·R·A·H·M·S AFP KRYPTOR test is indicated as a non-invasive screening tool, used in conjunction with clinical evaluation, to assess the risk of neural tube defects in the fetus in serum and plasma (heparin) and to diagnose neural tube defects in the fetus in amniotic fluid in the second trimester of pregnancy. The B·R·A·H·M·S AFP KRYPTOR test is indicated as a non-invasive screening tool, used in conjunction with clinical evaluation, in the diagnosis of patients suspected of having hepatocellular carcinoma or non-seminomatous germ cell tumors (NSGCTs) and in the monitoring of patients confirmed to have hepatocellular carcinoma or NSGCTs. *) B·R·A·H·M·S AFP KRYPTOR CAL (Product Code: 081691N): To correct the calibration standard stored in the B·R·A·H·M·S KRYPTOR compact PLUS/ KRYPTOR GOLD.

Dates and Status

Nov 14, 2024

Companies Making Similar Products
Companies providing products similar to "IVD Department quantitative AFP testing"